Goldman Sachs says Valeant has long road ahead, cuts rating
Posted by admin on Monday, November 2, 2015 · Leave a Comment
(Reuters) – Goldman Sachs on Monday downgraded Valeant Pharmaceuticals International Inc’s stock, nearly two weeks after an influential short seller accused the Canadian drug maker of cooking its books.


Filed under Uncategorized · Tagged with
Goldman Sachs says Valeant has long road ahead, cuts rating
Posted by admin on Monday, November 2, 2015 · Leave a Comment
(Reuters) – Goldman Sachs on Monday downgraded Valeant Pharmaceuticals International Inc’s stock, nearly two weeks after an influential short seller accused the Canadian drug maker of cooking its books.


Filed under Uncategorized · Tagged with